KIMBERLY ROZNOWSKI: Open Payments
NPI 1053399865 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$639 in 29 payments from 14 companies in 2025. Trend: 2023 $627 · 2024 $546 · 2025 $639
Food & beverage: $639
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $125 |
| Tris Pharma Inc | 5 | $105 |
| Corium, LLC | 4 | $68 |
| HARMONY BIOSCIENCES LLC | 2 | $52 |
| ABBVIE INC. | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Alkermes, Inc. | 1 | $29 |
Products named: SPRAVATO, Dyanavel XR, Azstarys, REXULTI, WAKIX, VRAYLAR, Xelstrym, CAPLYTA.
Industry payments across MI — which companies pay providers there.
